Nutra Pharma (NPHC)

Executive Summary

Nutra Pharma Corp. is a private biopharmaceutical company focused on acquiring, licensing, and commercializing therapies for neurological disorders, cancer, autoimmune diseases, and infectious diseases, including multiple sclerosis, HIV, adrenomyeloneuropathy, and pain. Founded in 2000 and headquartered in Weston, Florida, the company operates with a minimal valuation of approximately $2.1 million and no disclosed commercial products or active pipeline candidates. Despite a long operational history, Nutra Pharma appears to be in a pre-revenue stage with limited publicly available clinical progress, suggesting a high-risk profile for investors.

Upcoming Catalysts (preview)

• TBDPotential licensing or acquisition announcement to bolster pipeline10% success
• TBDRegulatory filing for any preclinical or clinical candidate5% success